Intravenous (IV) and subcutaneous (SC) formulations each play important roles in modern oncology care, with distinct ...
FDA has determined that NRx’s Abbreviated New Drug Application (ANDA) is “substantially complete” and received for review. Assigned GDUFA goal date is July 29, 2026. NRx has applied to FDA for use of ...
Background and objective: In the intensive care unit (ICU), intravenous medication errors (MEs) pose serious risks to critically ill patients. ICU nurses, as the main executors of intravenous ...
Placement cornerstoned by Merchant Biotech Fund and biotech investor Dr Daniel Tillett, who will join the board Funds to accelerate clinical trial strategy for lead program IV-infused psilocin ...
SAN ANTONIO – A San Antonio woman has spent the last decade developing a product and creating a company that aims to clearly label IV medications and reduce the risk of patients receiving the ...
The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. This Account discusses recent progress and challenges in binding free energy ...
Julia Ries Wexler is a writer focusing on all things health and wellness. She has over 10 years of experience in health journalism, and though she has written about pretty much every health topic ...
President Donald Trump signed an order Tuesday aimed at tightening restrictions on direct-to-consumer drug advertising, expanding his administration’s scrutiny against big pharmaceutical companies and ...
It's a sad and inconvenient fact that many drugs have to be administered in the form of a slow intravenous (IV) drip, as opposed to a single quick injection. That may be about to change, however, ...
Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback